Stay updated on GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy
Sign up to get notified when there's something new on the GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy page.

Latest updates to the GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant revisions, including the removal of detailed descriptions of a clinical trial for Adult Growth Hormone Deficiency (AGHD) and the addition of a new version revision number. The principal investigator's name has also been retained.SummaryDifference37%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check87 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy
Enter your email address, and we'll notify you when there's something new on the GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy page.